ConclusionWe confirmed that carriers of an MMR gene mutation were at increased risk of a wide variety of cancers, including some cancers not previously recognized as being a result of MMR mutations, and found no evidence of an increased risk of cancer for their noncarrier relatives. (Source: Journal of Clinical Oncology) read more..
HER2-Positive Breast Cancer: The Next Testis Cancer?HER2-Positive Breast Cancer: The Next Testis Cancer?
With cure rates for HER2-positive breast cancer climbing, Dr. Kathy Miller says research may soon follow the direction taken in testis cancer: finding similar cure rates with less therapy and less toxicity. Medscape Hematology-Oncology (Source: Medscape Today Headlines) read more..